Search research articles
Contact Us
Filters
Showing results (51-60 of 106) with videos related to
Page
of 11
Sort By:
Future Oncology (London, England)
|
February 22, 2018
CLL2-BXX Phase II trials: sequential, targeted treatment for eradication of minimal residual disease in chronic lymphocytic leukemia
Paula Cramer, Julia von Tresckow, Jasmin Bahlo, et al.
Haematologica
|
June 17, 2021
Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase III MabCute study
Simon Rule, Wolney Gois Barreto, Javier Briones, et al.
Frontiers in Immunology
|
April 9, 2021
SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients
Tatjana Schwarz, Kirsten Heiss, Yuvaraj Mahendran, et al.
International Journal of Molecular Sciences
|
October 26, 2024
Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept Study
Satendra Kumar, Liangliang Nan, Georgia Kalodimou, et al.
Cancer Research
|
June 20, 2012
Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia
Constance Baer, Rainer Claus, Lukas P Frenzel, et al.
European Journal of Haematology
|
November 19, 2016
Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial
Othman Al-Sawaf, Kirsten Fischer, Carmen D Herling, et al.
Haematologica
|
October 30, 2020
Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase 1b study (GO28440)
Stephan Stilgenbauer, Franck Morschhauser, Clemens-Martin Wendtner, et al.
Leukemia & Lymphoma
|
September 19, 2022
Pooled analysis of first-line treatment with targeted agents in patients with chronic lymphocytic leukemia aged 80 years and older
Florian Simon, Adam Giza, Sandra Robrecht, et al.
Annals of Hematology
|
February 16, 2013
Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization
Sandra Heesch, Martin Neumann, Stefan Schwartz, et al.
American Journal of Hematology
|
September 9, 2014
Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation
Petra Langerbeins, Raymonde Busch, Nadine Anheier, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 106) with videos related to
Sort By:
Page
of 11
Future Oncology (London, England)
|
February 22, 2018
CLL2-BXX Phase II trials: sequential, targeted treatment for eradication of minimal residual disease in chronic lymphocytic leukemia
Paula Cramer, Julia von Tresckow, Jasmin Bahlo, et al.
Haematologica
|
June 17, 2021
Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase III MabCute study
Simon Rule, Wolney Gois Barreto, Javier Briones, et al.
Frontiers in Immunology
|
April 9, 2021
SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients
Tatjana Schwarz, Kirsten Heiss, Yuvaraj Mahendran, et al.
International Journal of Molecular Sciences
|
October 26, 2024
Implementation of an Immunoassay Based on the MVA-T7pol-Expression System for Rapid Identification of Immunogenic SARS-CoV-2 Antigens: A Proof-of-Concept Study
Satendra Kumar, Liangliang Nan, Georgia Kalodimou, et al.
Cancer Research
|
June 20, 2012
Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia
Constance Baer, Rainer Claus, Lukas P Frenzel, et al.
European Journal of Haematology
|
November 19, 2016
Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial
Othman Al-Sawaf, Kirsten Fischer, Carmen D Herling, et al.
Haematologica
|
October 30, 2020
Venetoclax plus bendamustine-rituximab or bendamustine-obinutuzumab in chronic lymphocytic leukemia: final results of a phase 1b study (GO28440)
Stephan Stilgenbauer, Franck Morschhauser, Clemens-Martin Wendtner, et al.
Leukemia & Lymphoma
|
September 19, 2022
Pooled analysis of first-line treatment with targeted agents in patients with chronic lymphocytic leukemia aged 80 years and older
Florian Simon, Adam Giza, Sandra Robrecht, et al.
Annals of Hematology
|
February 16, 2013
Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization
Sandra Heesch, Martin Neumann, Stefan Schwartz, et al.
American Journal of Hematology
|
September 9, 2014
Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation
Petra Langerbeins, Raymonde Busch, Nadine Anheier, et al.
Page
of 11